A fixed dose combination of telmisartan, and a thiazide diuretic in the treatment of hypertension
The article gives an overview of the risk factors for hypertension and the appropriate indication for using a fixed combination of telmisartan and hydrochlorothiazide. It cites large, multicentre clinical trials that demonstrate the efficacy and safety of telmisartan in patients with hypertension and also a metaanalysis of treatment with either telmisartan alone (TELMI) or in combination with hydrochlorothiazide (HCTZ) which shows that it is a very well tolerated and safe treatment for patients across a wide age range.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Vnitrni lekarstvi - 59(2013), 5 vom: 14. Mai, Seite 397-401 |
| Sprache: |
Tschechisch |
|---|
| Weiterer Titel: |
Fixní kombinace telmisartanu a thiazidového diuretika v léčbě hypertenze |
|---|
| Beteiligte Personen: |
Vítovec, J [VerfasserIn] |
|---|
| Themen: |
0J48LPH2TH |
|---|
| Anmerkungen: |
Date Completed 03.12.2013 Date Revised 03.12.2018 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM228351510 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM228351510 | ||
| 003 | DE-627 | ||
| 005 | 20231224075720.0 | ||
| 007 | tu | ||
| 008 | 231224s2013 xx ||||| 00| ||cze c | ||
| 028 | 5 | 2 | |a pubmed24n0761.xml |
| 035 | |a (DE-627)NLM228351510 | ||
| 035 | |a (NLM)23767455 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a cze | ||
| 100 | 1 | |a Vítovec, J |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A fixed dose combination of telmisartan, and a thiazide diuretic in the treatment of hypertension |
| 246 | 3 | 3 | |a Fixní kombinace telmisartanu a thiazidového diuretika v léčbě hypertenze |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 03.12.2013 | ||
| 500 | |a Date Revised 03.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The article gives an overview of the risk factors for hypertension and the appropriate indication for using a fixed combination of telmisartan and hydrochlorothiazide. It cites large, multicentre clinical trials that demonstrate the efficacy and safety of telmisartan in patients with hypertension and also a metaanalysis of treatment with either telmisartan alone (TELMI) or in combination with hydrochlorothiazide (HCTZ) which shows that it is a very well tolerated and safe treatment for patients across a wide age range | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 650 | 7 | |a Benzimidazoles |2 NLM | |
| 650 | 7 | |a Benzoates |2 NLM | |
| 650 | 7 | |a Diuretics |2 NLM | |
| 650 | 7 | |a Hydrochlorothiazide |2 NLM | |
| 650 | 7 | |a 0J48LPH2TH |2 NLM | |
| 650 | 7 | |a Telmisartan |2 NLM | |
| 650 | 7 | |a U5SYW473RQ |2 NLM | |
| 700 | 1 | |a Slíva, J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vnitrni lekarstvi |d 1955 |g 59(2013), 5 vom: 14. Mai, Seite 397-401 |w (DE-627)NLM000011363 |x 0042-773X |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2013 |g number:5 |g day:14 |g month:05 |g pages:397-401 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2013 |e 5 |b 14 |c 05 |h 397-401 | ||